Enlivex Therapeutics Ltd. (ENLV)
NASDAQ·Healthcare·Biotechnology
$0.85
-3.56%
Mkt Cap $28.19M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Mar 30, 2026 | — | — | — | -$0.03 | -$0.23 | -666.67% | — | — |
| Q1 2026 Mar 25, 2026 | — | — | — | -$0.09 | $27.35 | +31791.77% | — | — |
| Q4 2025 Nov 14, 2025 | — | — | — | -$0.12 | -$0.09 | +25.00% | — | — |
| Q3 2025 Aug 29, 2025 | — | — | — | -$0.16 | -$0.08 | +50.00% | — | — |
| Q2 2025 May 30, 2025 | — | — | — | -$0.16 | -$0.15 | +6.25% | — | — |
| Q1 2025 Feb 26, 2025 | — | — | — | -$0.16 | -$0.24 | -47.75% | — | — |
| Q4 2024 Nov 29, 2024 | — | — | — | -$0.16 | -$0.12 | +25.00% | — | — |
| Q3 2024 Aug 30, 2024 | — | — | — | -$0.22 | -$0.16 | +27.27% | — | — |
| Q2 2024 Jun 14, 2024 | — | — | — | -$0.25 | -$0.22 | +12.00% | — | — |
| Q1 2024 Mar 29, 2024 | — | — | — | -$0.28 | -$0.48 | -71.43% | — | — |
| Q4 2023 Nov 9, 2023 | — | — | — | -$0.32 | -$0.32 | +0.00% | — | — |
| Q3 2023 Sep 1, 2023 | — | — | — | -$0.43 | -$0.37 | +13.95% | — | — |
| Q2 2023 Apr 4, 2023 | — | — | — | -$0.40 | -$0.39 | +2.50% | — | — |
| Q1 2023 Mar 31, 2023 | — | — | — | -$0.38 | -$0.39 | -2.63% | — | — |
| Q4 2022 Dec 5, 2022 | — | — | — | -$0.29 | -$0.31 | -6.90% | — | — |
| Q3 2022 Aug 22, 2022 | — | — | — | -$0.45 | -$0.54 | -20.00% | — | — |
| Q2 2022 May 27, 2022 | — | — | — | -$0.41 | -$0.45 | -9.76% | — | — |
| Q2 2022 Apr 29, 2022 | — | — | — | -$0.28 | -$0.26 | +7.14% | — | — |
| Q4 2021 Nov 22, 2021 | — | — | — | -$0.21 | -$0.19 | +9.52% | — | — |
| Q3 2021 Aug 9, 2021 | — | — | — | -$0.26 | -$0.17 | +34.62% | — | — |